✦ LIBER ✦

PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico

✍ Scribed by Mayen-Herrera, E.; Pozos, J.C.; Yang, M.; Cortina, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI20 Cost-Effectiveness of Adalimumab f

✍ M. Yang; M. Yang; M. Skup; Z.Y. Zhou; N. Hengst; M. Wolff; P.M. Mulani; J. Chao 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI7 COST-EFFECTIVENESS ANALYSIS OF ADAL

✍ S Johnson; A Kaltenboeck; C Horn; P Mulani; S Majethia; J Chao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PGI22 Cost-Effectiveness Analysis of Pro

✍ L. Pozo Urquizo; E. Latapi; H. Soto Molina; A.C. Polanco 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

W1289 Effectiveness of Adalimumab for th

✍ Barreiro, Manuel; Lorenzo, Aurelio; Seoane, Montserrat; Dominguez-Munoz, Enrique 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Infliximab dose escalation vs. initiatio

✍ G. G. KAPLAN; C. HUR; J. KORZENIK; B. E. SANDS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Adalimumab for the treatment of fistulas

✍ Steven N. Fine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views